🇺🇸 FDA
Patent

US 6117867

Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them

expired A61PA61P23/00

Quick answer

US patent 6117867 (Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them) held by Nauchno-Tekhnologicheskoe Predpriyatie Ligand (Tovarischestvo S Ogranichennoi Otvetstvennostiju) expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nauchno-Tekhnologicheskoe Predpriyatie Ligand (Tovarischestvo S Ogranichennoi Otvetstvennostiju)
Grant date
Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P23/00